Hamilton Point Investment Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.42M Sell
91,862
-1,158
-1% -$101K 1.19% 27
2026
Q1
$7.93M Sell
93,020
-654
-0.7% -$58.3K 1.22% 26
2025
Q4
$7.4M Buy
93,674
+44,991
+92% +$3.53M 1.13% 28
2025
Q3
$3.89M Buy
48,683
+54
+0.1% +$4.61K 0.61% 54
2025
Q2
$4.42M Sell
48,629
-2,234
-4% -$204K 0.73% 48
2025
Q1
$4.77M Buy
50,863
+59
+0.1% +$5.28K 0.86% 44
2024
Q4
$4.62M Buy
50,804
+1,884
+4% +$180K 0.82% 47
2024
Q3
$5.08M Sell
48,920
-235
-0.5% -$24K 0.9% 44
2024
Q2
$4.77M Buy
49,155
+16
+0% +$1.48K 0.91% 46
2024
Q1
$4.42M Sell
49,139
-2,820
-5% -$239K 0.85% 49
2023
Q4
$4.14M Buy
51,959
+575
+1% +$43.2K 0.83% 49
2023
Q3
$3.65M Sell
51,384
-970
-2% -$72.5K 0.9% 48
2023
Q2
$4.03M Sell
52,354
-1,715
-3% -$133K 0.96% 46
2023
Q1
$4.06M Buy
54,069
+1,097
+2% +$81.6K 0.99% 47
2022
Q4
$4.17M Buy
52,972
+454
+0.9% +$34K 1.15% 44
2022
Q3
$3.69M Buy
52,518
+1,453
+3% +$114K 1.12% 41
2022
Q2
$4.09M Buy
51,065
+726
+1% +$56.8K 1.19% 40
2022
Q1
$3.82M Buy
50,339
+576
+1% +$45.6K 0.98% 45
2021
Q4
$4.25M Buy
49,763
+1,285
+3% +$100K 1.01% 43
2021
Q3
$3.66M Buy
48,478
+231
+0.5% +$18.3K 0.97% 45
2021
Q2
$3.92M Buy
48,247
+446
+0.9% +$36.5K 1.06% 41
2021
Q1
$3.77M Buy
47,801
+1,162
+2% +$91.1K 1.09% 44
2020
Q4
$3.99M Buy
46,639
+234
+0.5% +$19.4K 1.26% 38
2020
Q3
$3.58M Buy
46,405
+296
+0.6% +$22.6K 1.26% 39
2020
Q2
$3.38M Buy
46,109
+1,303
+3% +$92.6K 1.3% 37
2020
Q1
$2.97M Buy
44,806
+1,887
+4% +$133K 1.38% 39
2019
Q4
$2.96M Buy
42,919
+94
+0.2% +$6.41K 1.12% 46
2019
Q3
$3.15M Buy
42,825
+2,314
+6% +$168K 1.29% 41
2019
Q2
$2.9M Buy
40,511
+496
+1% +$35.2K 1.24% 39
2019
Q1
$2.74M Buy
40,015
+432
+1% +$27.9K 1.22% 36
2018
Q4
$2.36M Buy
39,583
+2,004
+5% +$125K 1.2% 41
2018
Q3
$2.52M Buy
37,579
+113
+0.3% +$7.53K 1.18% 39
2018
Q2
$2.43M Buy
37,466
+710
+2% +$46.4K 1.2% 39
2018
Q1
$2.63M Buy
36,756
+1,494
+4% +$108K 1.34% 36
2017
Q4
$2.66M Buy
35,262
+1,245
+4% +$90.9K 1.39% 36
2017
Q3
$2.48M Buy
34,017
+206
+0.6% +$14.8K 1.34% 33
2017
Q2
$2.51M Buy
33,811
+215
+0.6% +$16K 1.41% 33
2017
Q1
$2.46M Sell
33,596
-25,853
-43% -$1.81M 1.4% 34
2016
Q4
$3.89M Sell
59,449
-341
-0.6% -$23.4K 2.4% 9
2016
Q3
$4.43M Buy
59,790
+1,400
+2% +$103K 2.79% 3
2016
Q2
$4.27M Sell
58,390
-8
-0% -$570 2.79% 3
2016
Q1
$4.13M Sell
58,398
-2,090
-3% -$139K 2.75% 3
2015
Q4
$4.03M Buy
60,488
+3,200
+6% +$213K 2.79% 3
2015
Q3
$3.63M Buy
57,288
+5,133
+10% +$335K 2.85% 3
2015
Q2
$3.41M Buy
52,155
+495
+1% +$33.6K 2.76% 6
2015
Q1
$3.58M Buy
51,660
+1,695
+3% +$117K 2.95% 4
2014
Q4
$3.46M Buy
49,965
+1,119
+2% +$75.6K 2.98% 3
2014
Q3
$3.19M Buy
48,846
+125
+0.3% +$8.24K 2.96% 3
2014
Q2
$3.32M Sell
48,721
-890
-2% -$59.6K 3.09% 1
2014
Q1
$3.22M Buy
49,611
+980
+2% +$61.8K 3% 1
2013
Q4
$3.17M Buy
+48,631
New +$3.11M 3.16% 1

Other funds holding CL

Hamilton Point Investment Advisors's CL Position: Q2 2026 in Review

Hamilton Point Investment Advisors reduced its Colgate-Palmolive (CL) stake by 1.2% in Q2 2026, selling an estimated $101K and leaving 91,862 shares worth $8.42M. The position accounts for 1.19% of the portfolio, ranked #27.

Hamilton Point Investment Advisors first reported a position in CL in Q4 2013 and has held it in 51 quarters since. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Hamilton Point Investment Advisors held 91,862 shares of Colgate-Palmolive worth $8.42M as of Q2 2026.
  • Hamilton Point Investment Advisors sold 1,158 Colgate-Palmolive shares in Q2 2026, an estimated $101K.
  • Colgate-Palmolive made up 1.19% of Hamilton Point Investment Advisors's portfolio in Q2 2026, its #27 holding.
  • Hamilton Point Investment Advisors first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 51 quarters since.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Hamilton Point Investment Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.